BioSpace News Archive

Ipsen announces that it has appointed an investment services provider to purchase 250,000 Ipsen SA shares, or about 0.30% of the share capital, over a period of at least 3 months.

Targovax ASA announces that CMO Magnus Jäderberg will present a company overview at the Jefferies 2018 Global Healthcare Conference.

CarThera announced the preliminary data of its Phase I/IIa clinical trial (NCT02253212) on ultrasound induced blood-brain barrier (BBB) opening.

Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery.

Tartu University Hospital has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally.

QIAGEN N.V. announced that it welcomes new guidelines from the American Academy of Pediatrics (AAP) that recommend screening at-risk children as young as two years old for latent tuberculosis (TB) infection.

RiseNow, LLC is proud to announce the addition of two new specialists to the RiseNow team.

DiviTum results from a large AstraZeneca study are presented today at the ASCO meeting in Chicago, the largest cancer congress in the world.

MiNA Therapeuticstoday announced preliminary results from its ongoing Phase I study of small activating RNA (saRNA) candidate MTL-CEBPA in advanced liver cancer.

Heliospectra AB announces a second order from 5 Leters DOO for additional E60 series LED grow lights as the company scales medicinal cannabis cultivation in Resen, Macedonia.